Digital Health Today Podcasts

In this episode, we speak about the global challenge of mental health. With COVID, the WHO is predicting that “the mental health impacts of the pandemic will be long term and far-reaching.” Everyone can be affected, including caregivers and clinicians. Nawal Roy is CEO of Holmusk, a leading startup helping address the global challenge of mental health through their real world evidence platform. In our conversation, we cover the following topics: • Understanding the main categories for mental health • Similarities of mental health challenges in APAC and around the world • Areas of opportunities for digital health • The current status and future needs of evidence to unlock clinical innovations Nawal Roy (Founder & CEO, Holmusk) Nawal Roy is Founder and CEO of Holmusk, bringing more than fifteen years of finance and strategy consulting experience to the helm of the company. After seeing first-hand the transformation of the finance sector driven by data and technology, Nawal decided to focus on helping transform healthcare in the same way. There is an urgent need for more behavioral health evidence and this need is what spurred Nawal to start Holmusk. Nawal carves out the strategic direction of Holmusk, leading from the front with round-the-clock hustle and infectious energy. Prior to this, Nawal was Co-Founder and CEO of HelloPay (Rocket Internet venture), and a Junior Partner at McKinsey & Company. He has served as a World Economic Value-Based Healthcare Steering Committee and co-founded Galen Growth Asia - The Asia Health Tech Connector. Having enjoyed a global career spanning from New York to Tokyo, his close involvement with markets across North America, Europe, Southeast Asia, India, and China yields uniquely diverse experience in building next generation global companies. Guest's Links and Resources Connect with Nawal Roy: LinkedIn Holmusk: Website | LinkedIn | Twitter Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Bayer G4A Takeda Roche

In this episode, we start our journey for Season 2 where we explore the challenges facing APAC that can lead to innovative solutions powered by Digital Health. Jeremy Lim is a renowned health policy expert and CEO of AMILI, the first gut microbiome lab in Singapore and Southeast Asia. Through the lens of population health and public policy, Jeremy and I discuss the need for personalised nutrition and why it can improve health outcomes. Our conversation covers: • The need for an Asia-based pool of data on nutrition based on the unique cultures and food choices found across the region • Why personalised nutrition is another reason for public health to innovate beyond a “one-size fits all” approach • The challenge of successfully using nudging behaviours to improve health outcomes • When is the optimal time to understand your microbiome? Assoc Prof Jeremy Lim is Co-founder and CEO of AMILI, the region’s first precision gut microbiome company which is building up the world’s largest multi-ethnic Asia database of microbiome sequences and associated data. He brings diverse and unique perspectives into this role as a startup founder, having spent substantial time in public and private healthcare across Asia as well as in policy advisory with Singapore's Ministry of Health, the World Bank and the World Health Organization. He is also director for global health in the NUS Saw Swee Hock School of Public Health. Outside academia, Jeremy serves on the boards of various for-profit and not-for-profit organizations in different aspects of healthcare including migrant worker health, end of life care and digital health interventions. He trained in surgery and public health, attaining post-graduate qualifications in both from the UK and US. Guest's Links and Resources Connect with Jeremy Lim: LinkedIn AMILI: Website | LinkedIn Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Bayer G4A Takeda Roche

Guest host Sophie Park interviews health economist Jane Sarasohn-Kahn for this fast-paced discussion about women's health, social determinants of health and the 'she-cession' in the wake of the COVID-19 pandemic. We've seen the headlines during COVID-19: Rising caseloads. Millions of lives lost. Economic devastation. Schools closed. But these only tell part of the story. The impact of the pandemic on mental and physical health extends far beyond those that are directly infected with the disease. Delayed diagnosis, canceled or delayed treatment, loss of employment and the collision of home and professional responsibilities has had a tremendous and long-lasting impact. Join Jane Sarasohn-Kahn and guest host Sophie Park in this discussion about the affects of the pandemic. For more discussion about women's health, check out the video panel with Jane and Sonia Millsom, Chief Commercial Officer of Maven Clinic, on the September 9 Digital Health Forum. Episode Links and Resources: Connect with Jane Sarasohn-Kahn: Website | Twitter | LinkedIn | Attend Digital Health Forum: Website | LinkedIn | Twitter Tune into Episode 16 with Kate Ryder, founder of Maven Clinic Guest Host Links Twitter @sophiemariepark Linkedin: https://www.linkedin.com/in/sophiemariepark/ Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Roche Takeda

Every day, tech companies and governments frame the conversation around the use of data. With the proliferation of smartphones and wearable devices, online shopping, and home voice assistants, we leave a digital footprint with almost everything we do. While our data can be crunched to drive better insights on listening habits, activity levels, and consumer preferences. There's also a far more important application for our data: to improve human lives and health outcomes. In this coffee talk, we explore how leaders in the pharmaceutical industry are working with people, policy makers and providers to create solutions that will usher in a new era of healthcare solutions and services. This Coffee Talk is created with support from Takeda. Guest Links and Resources: Connect with Meni Styliadou: LinkedIn Connect with Takeda: Website | Twitter | LinkedIn Connect with H2O: Website | Twitter | LinkedIn | YouTube European Patient Forum: Website Innovative Medicines Initiative: Website | Twitter | LinkedIn | YouTube Host Links Connect with Dan: Twitter | LinkedIn Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

The pandemic has illustrated how Social Determinants of Health (SDOH) can impact the spread of disease, access to vaccines and the levels of trust in and utilization of basic health services. Beyond the focus on SDOH by politicians, advocacy, groups, and charitable organizations, there are private and public commercial organizations that make it a priority to find and fund solutions that address the social and cultural barriers that reduce or limit access to care. One of those organizations is Bayer. In this conversation with Dominick Kennerson, Global Head of Bayer G4A, we discuss how equity, access and sustainability help set the course for their investment strategy. This Coffee Talk is created in partnership with our Sponsor, Bayer G4A. This year Bayer G4A is looking for companies creating solutions to 5 key challenges including oncology, radiology, mental health, women's health and cardio metabolic and renal diseases. The Bayer G4A program is open to companies from pre-seed stage to Series A, and even more advanced companies with traction in the market. Apply to be a part of Bayer G4A here, and tell them you heard about it on Digital Health Today. The deadline to apply is June 20, 2021. Guest Links and Resources: Connect with Dom Kennerson: Twitter | LinkedIn Connect with Bayer G4A: Website | Twitter | LinkedIn | YouTube World Health Organization - Website | Constitution Host Links Connect with Dan: Twitter | Linkedin Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram

Dr. David E Albert is a physician, engineer, inventor and serial entrepreneur, and he's the founder and Chief Medical Officer of Alivecor. Dr. Albert has developed life-saving technologies and products for more than 30 years, and he's turned a number of those inventions into tech startups, even before it was a trendy thing to do. Each year, over 20,000 students enrolled in medical schools across the US. Over 600,000 businesses are started each year in the US, and nearly half fail within five years; two-thirds fail within 10 years. So why do people who are on a path to a successful career in medicine decide to become entrepreneurs? Dr. Albert says that "a lot of people go into medicine because it's not very risky. And so there's a real juxtaposition between those people who go into medicine because it's a secure professional lifestyle, and being an entrepreneur." Back in January, 2011, Dr. Albert posted a four minute YouTube video showing how to turn an apple iPhone 4 into a wireless clinical quality cardiac event recorder. It's called AliveCor, and it looked like magic. Ten years later, the AliveCor company continues to grow and expand. Tune into this special episode as we highlight the twists of fate and deliberate decisions that shaped Dr. Albert's career, and hear how his work and companies continue to make a lasting impact in the delivery of care. Guest Links and Resources: Connect with Dr. Dave Albert: Twitter | LinkedIn | Connect with AliveCor: Website | Twitter | LinkedIn | YouTube Dr. Albert's 2011 YouTube video showing the AliveCor ECG Host Links Twitter @healthtechdan Linkedin: https://www.linkedin.com/in/dankendall/ Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Roche Takeda

In this final episode of Digital Therapeutics Edition, Eugene and his journalistic partner, Brian Dolan, reflect on the lessons learned, guest experts, and inspiring stories featured in season one. Brian is a journalist and the founder and lead writer of Exits & Outcomes, and in each episode, he asked the guests a pointed and challenging question about their digital solutions or their outlook on the DTx industry. It's been an eventful five months, Brian says -- companies have been bought, merged, and sold, and have raised impressive rounds of funding -- but there are other areas that have seen little progress since the podcast was launched. There may be a season 2 of Digital Therapeutics Edition, but in the meantime, head over to healthxl.com/dtx to continue the conversation with Eugene and other experts. What do you think the future of DTx will look like? >>Click here to read the transcript Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

Abhishek Shah, the CEO and founder of Wellthy Therapeutics, is driven by the challenge of improving care delivery and outcomes for serious or chronic diseases like hypertension, type 2 diabetes, and kidney disease. Abhishek decided to start Wellthy after a successful career as an investor; he was inspired by the incredible ideas of other entrepreneurs, and tired of sitting on the sidelines, decided to build something himself. Eugene and Abhishek talked back in December, and in that time, Wellthy has laid the groundwork for expansion throughout Asia Pacific and Europe. Eugene and Abhishek talk about his efforts to get investors to back Wellthy, the technology and regulatory landscape for DTx in South Asia, and whether Wellthy is facing competition from other industry players like Apollo during the COVID-19 pandemic. >>Click here to read the transcript Guest Links and Resources: Connect with Abhishek Shah: LinkedIn | Twitter Visit Wellthy Therapeutics: Twitter | LinkedIn | Facebook | Instagram | Website Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Follow Eugene's journey of writing his first book: Hard Pill to Swallow Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche